Results 231 to 240 of about 781,057 (345)

Advances in the Treatment of Diabetic Retinopathy with Anti-VEGF Therapy

open access: hybrid
M.P. González García   +9 more
openalex   +2 more sources

Insulin therapy DE‐intensificAtion with iGlarLixi: A phase 4, open‐label, parallel‐group randomised controlled trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the efficacy and safety of transitioning from multiple daily injections (MDIs) insulin regimen to once‐daily, fixed‐ratio combination of basal insulin analog glargine 100 U/mL and a glucagon‐like peptide 1 receptor agonist lixisenatide (iGlarLixi) in people with type 2 diabetes (PwT2D). Materials and Methods Insulin therapy DE‐
Peter Novodvorský   +14 more
wiley   +1 more source

Artificial Intelligence in Diabetic Retinopathy and Diabetic Macular Edema: A Narrative Review. [PDF]

open access: yesBioengineering (Basel)
Jukić A   +5 more
europepmc   +1 more source

CGM‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the associations of HbA1c and continuous glucose monitoring (CGM)‐derived average glucose with microvascular complications in adults with type 1 diabetes, and to assess the clinical utility and stability of metrics capturing glycation discordance. Materials and methods Observational assessment of 9023 paired measurements of CGM
Roland H. Stimson   +7 more
wiley   +1 more source

Interleukin-8 and tumor necrosis factor-? levels in vitreous samples from patients with diabetic retinopathy

open access: green, 2019
Rıfat Rasier   +6 more
openalex   +2 more sources

Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy